Hepatitis B virus X protein promotes proliferation of hepatocellular carcinoma cells by upregulating miR-181b by targeting ING5

References

Chen, Z., Tang, J., Cai, X., Huang, Y., Gao, Q., Liang, L., Tian, L., Yang, Y., Zheng, Y., Hu, Y., et al. (2016). HBx mutations promote hepatoma cell migration through the Wnt/beta-catenin signaling pathway. Cancer Sci. 107, 1380–1389.10.1111/cas.13014Search in Google Scholar PubMed PubMed Central

Han, H., Deng, H., Han, T., Zhao, H., Hou, F., and Qi, X. (2017). Association between hepatocellular carcinoma and type 2 diabetes mellitus in Chinese hepatitis B virus cirrhosis patients: a case-control study. Med. Sci. Monit. 23, 3324–3334.10.12659/MSM.902440Search in Google Scholar

Lei, R., Min, X., Lan, Z., and Lin, Z.Q. (2017). Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP. Onco Targets Ther. 10, 35–46.10.2147/OTT.S112686Search in Google Scholar PubMed PubMed Central

Li, X. (2010). Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 136, 1573–1583.10.1007/s00432-010-0815-xSearch in Google Scholar PubMed

Li, D., Jian, W., Wei, C., Song, H., Gu, Y., Luo, Y., and Fang, L. (2014). Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer. Int. J. Clin. Exp. Pathol. 7, 7672–7680.Search in Google Scholar

Li, L.Q., Yang, Y., Chen, H., Zhang, L., Pan, D., and Xie, W.J. (2016). MicroRNA-181b inhibits glycolysis in gastric cancer cells via targeting hexokinase 2 gene. Cancer Biomark. 17, 75–81.10.3233/CBM-160619Search in Google Scholar PubMed

Liu, S., Koh, S.S.Y., and Lee, C.G.L. (2016a). Hepatitis B virus X protein and hepatocarcinogenesis. Int. J. Mol. Sci. 17, 940.10.3390/ijms17060940Search in Google Scholar PubMed PubMed Central

Liu, Y., Uzair Ur, R., Guo, Y., Liang, H., Cheng, R., Yang, F., Hong, Y., Zhao, C., Liu, M., Yu, M., et al. (2016b). miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4. Protein Cell. 7, 722–734.10.1007/s13238-016-0313-2Search in Google Scholar PubMed PubMed Central

Liu, Y.S., Lin, H.Y., Lai, S.W., Huang, C.Y., Huang, B.R., Chen, P.Y., Wei, K.C., and Lu, D.Y. (2017). MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma. Oncogene 36, 5006–5022.10.1038/onc.2017.129Search in Google Scholar PubMed

Malki, A., El-Sharkawy, A., El, S.M., and Bergmeier, S. (2017). Antitumor activities of the novel isosteviol derivative 10C against liver cancer. Anticancer Res. 37, 1591–1601.10.21873/anticanres.11489Search in Google Scholar PubMed

Ng, I.O., Sze, K.M., and Chu, G.K. (2015). Role of hepatitis B virus X protein in liver cancer. Hong Kong Med. J. 21 (Suppl 4), 27–30.Search in Google Scholar

Ohgi, T., Masaki, T., Nakai, S., Morishita, A., Yukimasa, S., Nagai, M., Miyauchi, Y., Funaki, T., Kurokohchi, K., and Watanabe, S. (2002). Expression of p33 ING1 in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity. Scand. J. Gastroenterol. 37, 1440–1448.10.1080/003655202762671332Search in Google Scholar PubMed

Stewart, S.L., Dang, J.H., and Chen, M.S. (2017). Abstract B80: Multiple risk factors for hepatocellular carcinoma (HCC) among Asian Americans: implications for intervention. Cancer Epidemiol. Biomarkers Prev. 26, B80–B80.10.1158/1538-7755.DISP16-B80Search in Google Scholar

Tang, H., Oishi, N., Kaneko, S., and Murakami, S. (2006). Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci. 97, 977–983.10.1111/j.1349-7006.2006.00299.xSearch in Google Scholar PubMed

Tian, Y. and Ou, J.H. (2015). Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma. Virol. Sin. 30, 85–91.10.1007/s12250-015-3582-7Search in Google Scholar PubMed PubMed Central

Wang, B., Hsu, S.H., Majumder, S., Kutay, H., Huang, W., Jacob, S.T., and Ghoshal, K. (2010). TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene. 29, 1787–1797.10.1038/onc.2009.468Search in Google Scholar PubMed PubMed Central

Wang, H., Cao, G., Fu, J., and Lv, G. (2017). Hepatitis viruses and hepatoma. In: Holland‐Frei Cancer Medicine, (Hoboken, NJ, USA: Wiley Blackwell), pp. 1–6.10.1002/9781119000822.hfcm031Search in Google Scholar

Wu, H., Tao, J., Li, X., Zhang, T., Zhao, L., Wang, Y., Zhang, L., Xiong, J., Zeng, Z., and Zhan, N. (2017). MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma via modulating expression of cMet and Cdk6. Hepatology 66, 1952–1967.10.1002/hep.29374Search in Google Scholar PubMed PubMed Central

Xia, Y. and Gao, Y. (2014). MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2. Biochem. Biophys. Res. Commun. 447, 446–451.10.1016/j.bbrc.2014.04.027Search in Google Scholar PubMed

Xing, Y.N., Yang, X., Xu, X.Y., Zheng, Y., Xu, H.M., Takano, Y., and Zheng, H.C. (2011). The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression. Hum. Pathol. 42, 25–35.10.1016/j.humpath.2010.05.024Search in Google Scholar PubMed

Yang, H.Y., Liu, H.L., Tian, L.T., Song, R.P., Song, X., Yin, D.L., Liang, Y.J., Qu, L.D., Jiang, H.C., and Liu, J.R. (2012). Expression and prognostic value of ING3 in human primary hepatocellular carcinoma. Exp. Biol. Med. 237, 352–361.10.1258/ebm.2011.011346Search in Google Scholar PubMed

Yiyi, C., Juan, C., Dan, W., Hong, P., Xixi, T., Dongmei, X., Ailong, H., and Hua, T. (2015). Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Oncotarget 6, 38093–38106.10.18632/oncotarget.5642Search in Google Scholar PubMed PubMed Central

Yoo, J.O., Kwak, S.Y., An, H.J., Bae, I.H., Park, M.J., and Han, Y.H. (2016). miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG. Biochim. Biophys. Acta 1863, 1601–1611.10.1016/j.bbamcr.2016.04.016Search in Google Scholar PubMed

Zeng, Z.L., Li, F.J., Gao, F., Sun, D.S., and Yao, L. (2013). Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma. J. Surg. Oncol. 107, 105–110.10.1002/jso.23210Search in Google Scholar PubMed

Zhang, H.K., Pan, K., Wang, H., Weng, D.S., Song, H.F., Zhou, J., Huang, W., Li, J.J., Chen, M.S., and Xia, J.C. (2008). Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Lett. 261, 183–192.10.1016/j.canlet.2007.11.019Search in Google Scholar PubMed

Zhang, C.H., Hu, T., Yang, X.F., Li, S., Lv, X., He, S., Yan, H.X., Tan, Y.X., Chen, R.R., and Wen, M.L. (2017). Role of circulating miRNA-122a and miRNA-6086 in diagnosis and prognosis of hepatocellular carcinoma. J. Hunan Normal Univ. 14, 12–16.Search in Google Scholar

Zhao, G., Han, C., Zhang, Z., Wang, L., and Xu, J. (2017). Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line. Biochem. Biophys. Res. Commun. 490, 371–377.10.1016/j.bbrc.2017.06.050Search in Google Scholar PubMed

Zheng, H., Zou, A.E., Saad, M.A., Wang, X.Q., Kwok, J.G., Korrapati, A., Li, P., Kisseleva, T., Wang-Rodriguez, J., and Ongkeko, W.M. (2017). Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma. PLoS One 12, e0178547.10.1371/journal.pone.0178547Search in Google Scholar PubMed PubMed Central

Zhi, F., Wang, Q., Deng, D., Shao, N., Wang, R., Xue, L., Wang, S., Xia, X., and Yang, Y. (2014). MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma. PLoS One 9, e109124.10.1371/journal.pone.0109124Search in Google Scholar PubMed PubMed Central

Zhu, M., Guo, J., Li, W., Xia, H., Lu, Y., Dong, X., Chen, Y., Xie, X., Fu, S., and Li, M. (2015). HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells. BMC Cancer 15, 362.10.1186/s12885-015-1384-9Search in Google Scholar PubMed PubMed Central